Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Johnson and Johnson
Dow
Moodys
Express Scripts

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Litigation Details for VALEANT PHARMACEUTICALS INTERNATIONAL INC. v. PAR STERILE PRODUCTS, LLC (D.N.J. 2017)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

VALEANT PHARMACEUTICALS INTERNATIONAL INC. v. PAR STERILE PRODUCTS, LLC (D.N.J. 2017)

Docket   Start Trial Date Filed 2017-08-25
Court District Court, D. New Jersey Date Terminated 2018-05-15
Cause 35:271 Patent Infringement Assigned To Stanley R. Chesler
Jury Demand None Referred To Cathy L. Waldor
Parties ENDO INTERNATIONAL PLC; PAR PHARMACEUTICAL INC; PAR STERILE PRODUCTS, LLC; PROGENICS PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, INC.; VALEANT PHARMACEUTICALS INTERNATIONAL INC.; WYETH LLC
Patents 8,247,425; 8,420,663; 8,552,025; 8,822,490; 9,180,125; 9,669,096
Attorneys JOSEPH P. LASALA; KATHERINE ANN ESCANLAR; SEAN R. KELLY
Firms McElroy, Deutsch, Mulvaney & Carpenter, LLP; Saiber, LLC
Link to Docket External link to docket
Small Molecule Drugs cited in VALEANT PHARMACEUTICALS INTERNATIONAL INC. v. PAR STERILE PRODUCTS, LLC
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for VALEANT PHARMACEUTICALS INTERNATIONAL INC. v. PAR STERILE PRODUCTS, LLC (D.N.J. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 infringement of U.S. Patent Nos. 8,247,425 (“the ’425 patent”); 8,420,663 (“the ’663 patent”); 8,552,025 (“…021964, the ’025 patent, the ’425 patent, the ’663 patent, the ’490 patent, the ’125 patent, and the ’096… of the ’425 patent, the ’663 patent, the ’025 patent, the ’490 patent, the ’125 patent, and the ’096… of the ’425 patent, the ’663 patent, the ’025 patent, the ’490 patent, the ’125 patent, and the ’096… of the ’425 patent, the ’663 patent, the ’025 patent, the ’490 patent, the ’125 patent, and the ’096 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Harvard Business School
McKesson
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.